CARB-ES-19 multicenter study of carbapenemase-producing klebsiella pneumonia e and escherichia coli from all spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3

UDC.coleccionInvestigaciónes_ES
UDC.departamentoFisioterapia, Medicina e Ciencias Biomédicases_ES
UDC.grupoInvInvestigación en Microbiología (INIBIC)es_ES
UDC.institutoCentroINIBIC - Instituto de Investigacións Biomédicas de A Coruñaes_ES
UDC.journalTitleFrontiers in Microbiologyes_ES
UDC.startPage918362es_ES
UDC.volume13es_ES
dc.contributor.authorCañada-García, Javier E.
dc.contributor.authorMoure, Zaira
dc.contributor.authorSola-Campoy, Pedro Juan
dc.contributor.authorDelgado-Valverde, Mercedes
dc.contributor.authorCano, María E.
dc.contributor.authorGijón, Desiree
dc.contributor.authorGonzález, Mónica
dc.contributor.authorGracia-Ahufinger, Irene
dc.contributor.authorLarrosa, Nieves
dc.contributor.authorMulet, Xavier
dc.contributor.authorPitart, Cristina
dc.contributor.authorRivera, Alba
dc.contributor.authorBou, Germán
dc.contributor.authorCalvo-Montes, Jorge
dc.contributor.authorCantón, Rafael
dc.contributor.authorGonzález-López, Juan José
dc.contributor.authorMartínez-Martínez, Luis
dc.contributor.authorNavarro, Ferrán
dc.contributor.authorOliver, Antonio
dc.contributor.authorPalacios-Baena, Zaira R.
dc.contributor.authorPascual, Álvaro
dc.contributor.authorRuiz Carrascoso, Guillermo
dc.contributor.authorVila, Jordi
dc.contributor.authorAracil, Belén
dc.contributor.authorPérez-Vázquez, María
dc.contributor.authorOteo, Jesús
dc.date.accessioned2025-02-12T07:39:10Z
dc.date.available2025-02-12T07:39:10Z
dc.date.issued2022-06-30
dc.description.abstract[Abstract] Objectives: CARB-ES-19 is a comprehensive, multicenter, nationwide study integrating whole-genome sequencing (WGS) in the surveillance of carbapenemase-producing K. pneumoniae (CP-Kpn) and E. coli (CP-Eco) to determine their incidence, geographical distribution, phylogeny, and resistance mechanisms in Spain. Methods: In total, 71 hospitals, representing all 50 Spanish provinces, collected the first 10 isolates per hospital (February to May 2019); CPE isolates were first identified according to EUCAST (meropenem MIC > 0.12 mg/L with immunochromatography, colorimetric tests, carbapenem inactivation, or carbapenem hydrolysis with MALDI-TOF). Prevalence and incidence were calculated according to population denominators. Antibiotic susceptibility testing was performed using the microdilution method (EUCAST). All 403 isolates collected were sequenced for high-resolution single-nucleotide polymorphism (SNP) typing, core genome multilocus sequence typing (cgMLST), and resistome analysis. Results: In total, 377 (93.5%) CP-Kpn and 26 (6.5%) CP-Eco isolates were collected from 62 (87.3%) hospitals in 46 (92%) provinces. CP-Kpn was more prevalent in the blood (5.8%, 50/853) than in the urine (1.4%, 201/14,464). The cumulative incidence for both CP-Kpn and CP-Eco was 0.05 per 100 admitted patients. The main carbapenemase genes identified in CP-Kpn were bla OXA-48 (263/377), bla KPC-3 (62/377), bla VIM-1 (28/377), and bla NDM-1 (12/377). All isolates were susceptible to at least two antibiotics. Interregional dissemination of eight high-risk CP-Kpn clones was detected, mainly ST307/OXA-48 (16.4%), ST11/OXA-48 (16.4%), and ST512-ST258/KPC (13.8%). ST512/KPC and ST15/OXA-48 were the most frequent bacteremia-causative clones. The average number of acquired resistance genes was higher in CP-Kpn (7.9) than in CP-Eco (5.5). Conclusion: This study serves as a first step toward WGS integration in the surveillance of carbapenemase-producing Enterobacterales in Spain. We detected important epidemiological changes, including increased CP-Kpn and CP-Eco prevalence and incidence compared to previous studies, wide interregional dissemination, and increased dissemination of high-risk clones, such as ST307/OXA-48 and ST512/KPC-3.es_ES
dc.description.sponsorshipThis research was supported by grants from the Instituto de Salud Carlos III (numbers PI18CIII/00030 and PI21CIII/00039). It was also supported by Plan Nacional de I + D + i 2013–2016, Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Economía y Competitividad, Spanish Network for Research in Infectious Diseases (grants RD16CIII/0004/0002, RD16/0016/0001, RD16/0016/0003, RD16/0016/0004, RD16/0016/0006, RD16/0016/0007, RD16/0016/0008, RD16/0016/0010, and RD16/0016/0011). Cofinanced by the European Development Regional Fund “A way to achieve Europe,” Operative Program Intelligent Growth 2014–2020. CIBER – Consorcio Centro de Investigación Biomédica en Red (CB21/13/00095, CB21/13/00012, CB21/13/00049, CB21/13/00054, CB21/13/00055, CB21/13/00068, CB21/13/00081, CB21/13/00084, and CB21/13/00099) (CIBERINFEC) and Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU also supported this work.es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PI18CIII/00030es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; PI21CIII/00039es_ES
dc.description.sponsorshipEspaña. Ministerio de Economía y Competitividad; RD16CIII/0004/0002es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0001/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0003/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0004/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0006/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0007/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0008/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0010/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/MINECO/Programa Estatal de I+D+I Orientada a los Retos de la Sociedad/RD16%2F0016%2F0011/ES/RED ESPAÑOLA DE INVESTIGACIÓN EN PATOLOGÍAS INFECCIOSASes_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00095es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00012es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00049es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00054es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00055es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00068es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00081es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00084es_ES
dc.description.sponsorshipInstituto de Salud Carlos III; CB21/13/00099es_ES
dc.identifier.citationCañada-García JE, Moure Z, Sola-Campoy PJ, Delgado-Valverde M, Cano ME, Gijón D, González M, Gracia-Ahufinger I, Larrosa N, Mulet X, Pitart C, Rivera A, Bou G, Calvo J, Cantón R, González-López JJ, Martínez-Martínez L, Navarro F, Oliver A, Palacios-Baena ZR, Pascual Á, Ruiz-Carrascoso G, Vila J, Aracil B, Pérez-Vázquez M, Oteo-Iglesias J; GEMARA/GEIRAS-SEIMC/REIPI CARB-ES-19 Study Group. CARB-ES-19 multicenter study of carbapenemase-producing klebsiella pneumonia e and escherichia coli from all spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3. Front Microbiol. 2022 Jun 30;13:918362.es_ES
dc.identifier.doi10.3389/fmicb.2022.918362
dc.identifier.issn1664-302X
dc.identifier.urihttp://hdl.handle.net/2183/41161
dc.language.isoenges_ES
dc.publisherFrontiers Mediaes_ES
dc.relation.urihttps://doi.org/10.3389/fmicb.2022.918362es_ES
dc.rightsCreative Commons Attribution 4.0 International License (CC-BY 4.0)es_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectCARB-ES-19 studyes_ES
dc.subjectKlebsiella pneumoniaees_ES
dc.subjectCarbapenemaseses_ES
dc.subjectHigh-risk cloneses_ES
dc.subjectWhole genome sequencinges_ES
dc.titleCARB-ES-19 multicenter study of carbapenemase-producing klebsiella pneumonia e and escherichia coli from all spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3es_ES
dc.typejournal articlees_ES
dspace.entity.typePublication
relation.isAuthorOfPublication909e08d1-6ed1-4b99-9e9e-c64eb72e7dea
relation.isAuthorOfPublication.latestForDiscovery909e08d1-6ed1-4b99-9e9e-c64eb72e7dea

Files

Original bundle

Now showing 1 - 5 of 6
Loading...
Thumbnail Image
Name:
Canada_CARB_ES-19_2022.pdf
Size:
3.64 MB
Format:
Adobe Portable Document Format
Description:
Loading...
Thumbnail Image
Name:
Canada_CARB_ES-19_2022_Suppl_1.pdf
Size:
243.79 KB
Format:
Adobe Portable Document Format
Description:
Table 1
Loading...
Thumbnail Image
Name:
Canada_CARB_ES-19_2022_Suppl_2.pdf
Size:
634.12 KB
Format:
Adobe Portable Document Format
Description:
Table 2
Loading...
Thumbnail Image
Name:
Canada_CARB_ES-19_2022_Suppl_3.pdf
Size:
252.71 KB
Format:
Adobe Portable Document Format
Description:
Table 3
Loading...
Thumbnail Image
Name:
Canada_CARB_ES-19_2022_Suppl_4.pdf
Size:
185.17 KB
Format:
Adobe Portable Document Format
Description:
Table 4